Free Access: Please Log In
This content is completely free—but you need to be logged in to read the full article. If you already have an account, please log in below. Otherwise, register for free to unlock instant access.
References (10)
- Damkier P, Videbech P. The safety of second-generation antipsychotics during pregnancy: a clinically focused review. CNS Drugs. 2018;32(4):351–366. PubMed CrossRef
- Andrade C. Major congenital malformations associated with exposure to second-generation antipsychotic drugs during pregnancy. J Clin Psychiatry. 2021;82(5):21f14252. PubMed CrossRef
- Andrade C. Gestational and neurodevelopmental outcomes associated with antipsychotic drug exposure during pregnancy. J Clin Psychiatry. 2021;82(5):21f14265. PubMed CrossRef
- Andrade C. Attention-deficit/hyperactivity disorder, autism spectrum disorder, and other neurodevelopmental outcomes associated with antipsychotic drug exposure during pregnancy. J Clin Psychiatry. 2022;83(3):22f14529. PubMed CrossRef
- Breadon C, Kulkarni J. An update on medication management of women with schizophrenia in pregnancy. Expert Opin Pharmacother. 2019;20(11):1365–1376. PubMed CrossRef
- Mendhekar DN, Andrade C. Uneventful use of haloperidol and trihehexyphenidyl during three consecutive pregnancies. Arch Womens Ment Health. 2011;14(1):83–84. PubMed CrossRef
- Robottom BJ, Reich SG. Exposure to high dosage trihexyphenidyl during pregnancy for treatment of generalized dystonia: case report and literature review. Neurologist. 2011;17(6):340–341. PubMed CrossRef
- Goyal SK, Goel A. Successful use of risperidone, trihexyphenidyl, and paroxetine in pregnancy. Indian J Psychol Med. 2017;39(6):835–836. PubMed CrossRef
- Mendhekar D, Lohia D. Risperidone therapy in two successive pregnancies. J Neuropsychiatry Clin Neurosci. 2008;20(4):485–486. PubMed CrossRef
- Edinoff AN, Silverblatt NS, Vervaeke HE, et al. Hyperprolactinemia, clinical considerations, and infertility in women on antipsychotic medications. Psychopharmacol Bull. 2021;51(2):131–148. PubMed
Please sign in or purchase this PDF for $40.